Clemastine fumarate syrup
Company: Morton Grove Pharmaceuticals
Approval Status: Approved March 1998
Treatment for: allergic rhinitis
Areas: Immunology/Infectious Diseases; Pulmonary/Respiratory Diseases
General Information
Other Useful Resources
Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
